Announces Archives - Best Allergy Medicine HQ

Lupin Announces FDA Approval of Supplemental New Drug Application for Solosec (secnidazole) for the Treatment of Trichomoniasis

06/07/2021 mediabest Medications

BALTIMORE, July 1, 2021 /PRNewswire/ –Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin),

Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients

31/03/2021 mediabest Medications

DUBLIN, March 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised

Adamas Announces FDA Approval for Second Indication for Gocovri as an Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes

03/02/2021 mediabest Medications

EMERYVILLE, Calif.–(BUSINESS WIRE)–Feb. 1, 2021– Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make

Propranolol 40 mg reviews

01/12/2020 mediabest Top

Order Medicines & Health Products from Online Pharmacy for Skin, Hair, Heart and all Personal Daily Health. Baby, Men, Women & Elderly care Products Online. Buy prescription medicines, OTC products & household needs.

Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

13/11/2020 mediabest Medications

VANCOUVER, British Columbia, Oct. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or

ViiV Healthcare Announces Analysis Showing no Antiretroviral Therapy Interruptions Due to COVID-19 Across its Clinical Development Programme for Investigational, Long-Acting Cabotegravir and Rilpivirine

21/10/2020 mediabest Medications

21 October 2020 — ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi

Italian PM announces stricter measures to counter virus

19/10/2020 mediabest Health News

Italian Prime Minister Giuseppe Conte on Sunday announced a new series of measures to tackle the rising number of virus

Kiniksa Announces U.S. Orphan Drug Designation for Mavrilimumab for the Treatment of Giant Cell Arteritis

19/09/2020 mediabest Medications

HAMILTON, Bermuda, Sept. 15, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing

Where to buy cheap tribulus au without prescription

27/02/2020 mediabest Top

BiP's Jenna Cooper Announces Pregnancy: 'See You in a Few Months'

25/01/2020 mediabest Kids Health

Baby on board! Jenna Cooper revealed she’s expecting her first child in a surprise announcement on Instagram. The Bachelor in